Get the app
Shlomi Madar
PhD-trained molecular biologist and CEO of SpotitEarly, leading the company’s U.S. buildout to combine canine olfaction with AI for early cancer detection and clinical validation.
Best podcasts with Shlomi Madar
Ranked by the Snipd community
Feb 4, 2026
• 1h 3min
SpotitEarly CEO Shlomi Madar on How Their Dogs Can Sniff Early-Stage Cancer, Why Dogs + AI is a Critical Combination, and Whether Cancer Screening Should be Regulated
chevron_right
Dr. Shlomi Madar, a PhD-trained molecular biologist and CEO of SpotitEarly building canine+AI cancer screening, explains how trained beagles sniff VOCs from breath in three minutes. He discusses why dogs plus machine learning boost accuracy, plans for direct-to-consumer $250/year kits, and regulatory and clinical validation challenges for scaling this approach.
The AI-powered Podcast Player
Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
Get the app
